DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

Eli Lilly & Co. (NYSE: LLY)

74.32 0.04 (0.05%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

LLY $74.32 0.05%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $74.16
Previous Close $74.28
Daily Range $73.55 - $75.82
52-Week Range $68.31 - $92.85
Market Cap $82.4B
P/E Ratio 21.66
Dividend (Yield) $2.04 (2.7%)
Ex-Dividend Date
Dividend Pay Date
02/10/16
03/10/16
Volume 6,312,782
Average Daily Volume 5,143,786
Current FY EPS $3.42

Sector

Healthcare

Industry

Drug Makers

Eli Lilly & Co. (LLY) Description

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases. Website: http://www.lilly.com/

News & Commentary Rss Feed

2 Numbers in Merck's 4th-Quarter Report That Have Investors Worried

Merck may have surpassed Wall Street's profit forecast, but these two numbers suggest that growth may be challenged in 2016.

Novo Nordisk A/S Taps the Growth Brakes

The diabetes specialist expects to see slowing operating growth, but it has a good reason.

ImmunoGen, Inc.'s Earnings Play the Amortization Blues

Keep focused on the pipeline because revenue and earnings are going to be bumpy for some time.

See Which Of The Latest 13F Filers Holds Eli Lilly

Wall Street Is as Bearish as 2009: 4 Top Dividend Stocks to Buy Right Now

3 Numbers That Matter When Merck Reports Its Fourth-Quarter Results

These three figures may prove far more important than Merck's fourth-quarter and full-year headline results.

Jim Cramer's Long-Term View on Health Care Stocks

Forget Biosimilars: It's This Threat That Could Dent AbbVie's Top Line

A potential approval this year of a drug that may work better than Humira could imperil sales of the company's best-seller.

Drug Pricing In The U.S. Under Pressure From Multiple Fronts - Is It Time To Stay Away From Innovato

Drug Pricing In The U.S. Under Pressure From Multiple Fronts - Is It Time To Stay Away From Innovator Pharma?

Eli Lilly And Company (LLY) Earnings Report: Q4 2015 Conference Call Transcript

See More LLY News...

LLY's Top Competitors

LLY $74.32 (0.05%)
Current stock: LLY
JNJ $100.54 (-3.23%)
Current stock: JNJ
NVS $74.33 (-0.97%)
Current stock: NVS
RHHBY $31.69 (-1.18%)
Current stock: RHHBY